Tm Bioscience Supplies Labcorp With Tag-It Cystic Fibrosis Reagents
News Oct 14, 2005
Tm Bioscience Corporation has announced that it is now supplying Laboratory Corporation of America Holdings with Tag-It CF70 reagents for use in their 70 mutation cystic fibrosis assay.
“We are delighted that LabCorp, one of the foremost providers of diagnostic testing in the U.S., has adopted additional products from our standardized Tag-It menu,” said Greg Hines, President and CEO of Tm Bioscience.
“Our CF70 reagents are the latest in a suite of products Tm has developed enabling high throughput laboratories to better serve the burgeoning CF market with more competitive and comprehensive offerings.”
“These reagents will allow LabCorp to serve additional segments of the ethnically diverse U.S. population.”
As previously announced, LabCorp has signed a master purchase agreement with Tm for the Company’s suite of Tag-It products.
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018